New linear accelerator goes into service in Radiation Oncology
Anti-cancer treatment is now under way with a highly sophisticated and versatile linear accelerator that’s newly installed at the JGH.
Researchers inch closer to better understanding of brain tumours in children
Certain brain cells may be inherently vulnerable to mutations that cause fatal brain tumours in children, says a study co-led by an LDI researcher.
Dr. Solon Schur joins JGH as skull base neurosurgical oncologist
Dr. Solon Schur has joined the JGH Division of Neurosurgery as a member of staff and as Assistant Professor of Neurosurgery.
New JGH lab launched to test potentially revolutionary cancer treatment
A potential breakthrough in cancer treatment, using magnetism to guide medication-carrying bacteria into tumours, will be tested in a new JGH lab.
Major construction to install new cancer-fighting linear accelerator in Radiation Oncology
Construction is under way to install a fourth linear accelerator in Radiation Oncology, making cancer treatment faster and more accurate.
Dr. April Rose joins Division of Medical Oncology
Dr. April Rose has joined the JGH as Attending Staff in the Division of Medical Oncology and in the Segal Cancer Centre.
Dr. Michael Pollak to co-lead Metastatic Breast Cancer Dream Team
Dr. Michael Pollak, Director of the Stroll Cancer Prevention Centre at the JGH, has been chosen to serve as one of two leaders of a new Canada-wide team, aimed at translating fundamental research about breast cancer into effective treatment options for patients.
JGH leads Canada in performing advanced robotic surgery for gynecologic cancer
The JGH has become the first hospital in Canada to perform an advanced type of robotic surgery for gynecologic cancer, in which all of the medical instruments are inserted into the abdomen via a single, tiny incision in the navel.
Promising therapy for relapsed patients with aggressive form of lymphoma
A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.
Segal Cancer Centre joins the “Cancer Moonshot”
The Segal Cancer Centre is taking “one small step” that could lead to “one giant leap” in a metaphorical moonshot to conquer cancer.